Gapol, Erolyn .

HRN: 26-51-90  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/14/2025
CEFUROXIME 1.5GM (VIAL)
01/14/2025
01/20/2025
IVT
1.5g
Q8hrs
UTI; G1P0
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: